Voices
Shreyas Kalantri
Shreyas Kalantri/X

Shreyas Kalantri: New Publication on Stage III – IV Melanoma Before and After the Immunotherapy Era

Shreyas Kalantri, Hematology and Oncology Chief Fellow at the University of Louisville, shared a post on X:

“Thrilled to share our new publication in JCO Oncology Practice! “Survival Outcomes in Stage III–IV Melanoma Before and After the Immunotherapy Era: Persistent Racial and Socioeconomic Disparities.” Despite major survival gains in the immunotherapy era, inequities persist.”

Title: Survival Outcomes in Stage III to IV Melanoma Before and After the Immunotherapy Era: Persistent Racial and Socioeconomic Disparities

Authors: Shreyas Kalantri, Pranali Pachika, Tyler Jones, Maiying Kong, Goetz Kloecker, Jason Chesney

Read the Full Article.

Shreyas Kalantri: New Publication on Stage III – IV Melanoma Before and After the Immunotherapy Era

More from Shreyas Kalantri on OncoDaily.

cancer Goetz Kloecker immunotherapy Jason Chesney Maiying Kong OncoDaily Oncology Pranali Pachika Shreyas Kalantri Tyler Jones